, where the authors did not report significant differences in the incidence of adverse events between the placebo group and the D-allulose groups (Reference Tanaka, Kanasak and Hayashi41)
Most stability loss occurs during the first temperature excursion, not through gradual decay over the stated storage period
The DPP-4 inhibitors prolong the action of endogenous incretins, enhancing the first-phase insulin response
Diet quality, meal timing, movement, sleep and stress all influence how much GLP-1 you produce and how effectively it works
Some are designed for slower, sustained absorption, while others deliver results more quickly
Your healthcare provider adjusts your tirzepatide dose based on your individual tolerance, weight loss progress, and metabolic response, ensuring you reach an optimal dose that balances efficacy with side effect management